Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

August 31, 2011

Conditions

Colon CancerPrecancerous ConditionRectal Cancer

Interventions

DRUG

acetylsalicylic acid

Given orally

DRUG

placebo

Given orally

OTHER

laboratory biomarker analysis

Correlative study

Trial Locations (1)

Northwestern University, Chicago

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00468910 - Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer | Biotech Hunter | Biotech Hunter